Safety profile of rapamycin perfluorocarbon nanoparticles for preventing cisplatin-induced kidney injury

Authors

Qingyu Zhou, University of South Florida
Justin Doherty, University of South Florida
Antonina Akk, Washington University School of Medicine in St. Louis
Luke E Springer, Washington University School of Medicine in St. Louis
Ping Fan, Duke University
Ivan Spasojevic, Duke University
Ganesh V Halade, University of South Florida
Huanghe Yang, Duke University
Christine T N Pham, Washington University School of Medicine in St. Louis
Samuel A Wickline, University of South Florida
Hua Pan, University of South Florida

Journal

Nanomaterials

Publication Date

1-21-2022

Volume

12

Issue

3

First Page

336

Document Type

Open Access Publication

DOI

10.3390/nano12030336

Rights and Permissions

Zhou Q, Doherty J, Akk A, Springer LE, Fan P, Spasojevic I, Halade GV, Yang H, Pham CTN, Wickline SA, Pan H. Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury. Nanomaterials (Basel). 2022 Jan 21;12(3):336. doi: 10.3390/nano12030336. Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Zhou, Qingyu; Doherty, Justin; Akk, Antonina; Springer, Luke E; Fan, Ping; Spasojevic, Ivan; Halade, Ganesh V; Yang, Huanghe; Pham, Christine T N; Wickline, Samuel A; and Pan, Hua, "Safety profile of rapamycin perfluorocarbon nanoparticles for preventing cisplatin-induced kidney injury." Nanomaterials. 12, 3. 336 (2022).
https://digitalcommons.wustl.edu/oa_4/3473

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.